Article Information
History
- April 7, 2020.
Article Versions
- Version 1 (March 9, 2020 - 21:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Camille Tlemsani1,†,*,
- Lorinc Pongor1,†,
- Luc Girard4,
- Nitin Roper1,
- Fathi Elloumi1,
- Sudhir Varma1,
- Augustin Luna5,
- Vinodh N. Rajapakse1,
- Robin Sebastian1,
- Kurt W. Kohn1,
- Julia Krushkal2,
- Mirit Aladjem1,
- Beverly A. Teicher2,
- Paul S. Meltzer3,
- William C. Reinhold1,
- John D. Minna4,
- Anish Thomas1 and
- Yves Pommier1,6
- 1Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
- 2Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Dr., Rockville, MD 20850, USA
- 3Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
- 4Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA
- 5cBio Center, Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA 02115, USA
- ↵6To whom correspondence should be addressed: pommier{at}nih.gov
↵† Contributed equally to the study